Author: Rebecca James

HERTFORDSHIRE, England, PITTSBURGH and SYDNEY, July 8, 2019 – Global pharmaceutical company Mylan N.V.(NASDAQ: MYL) and medical device manufacturer Atomo Diagnostics today announced that the Mylan HIV Self Test, a handheld in vitro HIV rapid diagnostic test for self-testing, has received Prequalification approval by the World Health Organization (WHO...

Seoul, Korea and Sydney, Australia – 29 April 2019 | Access Bio Inc. and Atomo Diagnostics today announced that they have developed a best-in-class rapid diagnostic test (RDT) for screening for hepatitis C virus (HCV). The companies have also collaborated to create a version for professional...

SYDNEY, Australia,4 April 2019 | Award-winning medical device developer Atomo Diagnostics today announced that its Atomo HIV Self Test – the first and only diagnostic self-test for HIV that has been formally reviewed and approved by the Therapeutic Goods Administration (TGA) – is now available to the Australian public.  The...